392 related articles for article (PubMed ID: 10503998)
1. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan.
Sato K; Miyakawa M; Eto M; Inaba T; Matsuda N; Shiga T; Ohnishi S; Kasanuki H
Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998
[TBL] [Abstract][Full Text] [Related]
2. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E
Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
[TBL] [Abstract][Full Text] [Related]
3. Color-flow Doppler sonography in the differential diagnosis and management of amiodarone-induced thyrotoxicosis.
Loy M; Perra E; Melis A; Cianchetti ME; Piga M; Serra A; Pinna G; Mariotti S
Acta Radiol; 2007 Jul; 48(6):628-34. PubMed ID: 17611870
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin-6 in amiodarone-induced thyrotoxicosis.
Bartalena L; Grasso L; Brogioni S; Aghini-Lombardi F; Braverman LE; Martino E
J Clin Endocrinol Metab; 1994 Feb; 78(2):423-7. PubMed ID: 8106631
[TBL] [Abstract][Full Text] [Related]
5. [Amiodarone and the thyroid gland].
Bednarek-Tupikowska G; Filus A; Kuliczkowska J; Bugajski J
Postepy Hig Med Dosw (Online); 2004 Apr; 58():216-25. PubMed ID: 15114257
[TBL] [Abstract][Full Text] [Related]
6. Amiodarone and thyroid dysfunction.
Padmanabhan H
South Med J; 2010 Sep; 103(9):922-30. PubMed ID: 20689491
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of amiodarone-induced thyrotoxicosis and hypothyroidism].
Gerber H; Noth D
Ther Umsch; 1999 Jul; 56(7):374-9. PubMed ID: 10434774
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone-induced thyroid dysfunction.
Danzi S; Klein I
J Intensive Care Med; 2015 May; 30(4):179-85. PubMed ID: 24067547
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography.
Eaton SE; Euinton HA; Newman CM; Weetman AP; Bennet WM
Clin Endocrinol (Oxf); 2002 Jan; 56(1):33-8. PubMed ID: 11849244
[TBL] [Abstract][Full Text] [Related]
10. Treatment of amiodarone-associated thyrotoxicosis.
Franklyn JA; Gammage MD
Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):662-6. PubMed ID: 17710087
[TBL] [Abstract][Full Text] [Related]
11. Mild and short recurrence of type II amiodarone-induced thyrotoxicosis in three patients receiving amiodarone continuously for more than 10 years.
Sato K; Shiga T; Matsuda N; Onoda N; Takano K; Hagiwara N; Kasanuki H
Endocr J; 2006 Aug; 53(4):531-8. PubMed ID: 16829703
[TBL] [Abstract][Full Text] [Related]
12. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis.
Bogazzi F; Martino E; Dell'Unto E; Brogioni S; Cosci C; Aghini-Lombardi F; Ceccarelli C; Pinchera A; Bartalena L; Braverman LE
J Endocrinol Invest; 2003 Jul; 26(7):635-40. PubMed ID: 14594114
[TBL] [Abstract][Full Text] [Related]
13. The clinical value of regular thyroid function tests during amiodarone treatment.
Benjamens S; Dullaart RPF; Sluiter WJ; Rienstra M; van Gelder IC; Links TP
Eur J Endocrinol; 2017 Jul; 177(1):9-14. PubMed ID: 28424174
[TBL] [Abstract][Full Text] [Related]
14. Amiodarone-induced thyrotoxicosis. A review.
Piga M; Serra A; Boi F; Tanda ML; Martino E; Mariotti S
Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027
[TBL] [Abstract][Full Text] [Related]
15. [The effects of amiodarone on the thyroid].
Toni M; Anda E; Pineda J; Martínez de Esteban JP; Ollero MD
An Sist Sanit Navar; 2009; 32(3):363-70. PubMed ID: 20094097
[TBL] [Abstract][Full Text] [Related]
16. Approach to the patient with amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Martino E
J Clin Endocrinol Metab; 2010 Jun; 95(6):2529-35. PubMed ID: 20525904
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations.
Bogazzi F; Bartalena L; Tomisti L; Rossi G; Tanda ML; Dell'Unto E; Aghini-Lombardi F; Martino E
J Clin Endocrinol Metab; 2007 Feb; 92(2):556-62. PubMed ID: 17148557
[TBL] [Abstract][Full Text] [Related]
18. Differential diagnosis and clinical course of amiodarone-induced thyroid dysfunction.
Alyan O; Arda K; Ozdemir O; Acu B; Soylu M; Demirkan D
Med Sci Monit; 2003 Sep; 9(9):PI117-22. PubMed ID: 12960935
[TBL] [Abstract][Full Text] [Related]
19. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
[TBL] [Abstract][Full Text] [Related]
20. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study.
Bartalena L; Brogioni S; Grasso L; Bogazzi F; Burelli A; Martino E
J Clin Endocrinol Metab; 1996 Aug; 81(8):2930-3. PubMed ID: 8768854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
